Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 21

1.

Risk factors associated with pulmonary exacerbations in pediatric patients with cystic fibrosis.

Lubovich S, Zaragoza S, Rodríguez V, Buendía J, Camargo Vargas B, Alchundia Moreira J, Galanternik L, Ratto P, Teper A.

Arch Argent Pediatr. 2019 Oct 1;117(5):e466-e472. doi: 10.5546/aap.2019.eng.e466. English, Spanish.

2.

Comparison of four pharmacological strategies aimed to prevent the lung inflammation and paraquat-induced alveolar damage.

Buendía JA, Justinico Castro JA, Vela LJT, Sinisterra D, Sánchez Villamil JP, Zuluaga Salazar AF.

BMC Res Notes. 2019 Sep 18;12(1):584. doi: 10.1186/s13104-019-4598-0.

3.

Costo de la intoxicación por Paraquat en Colombia.

Buendía JA, Restrepo Chavarriaga GJ.

Value Health Reg Issues. 2019 Jun 7;20:110-114. doi: 10.1016/j.vhri.2019.02.006. [Epub ahead of print]

PMID:
31181392
4.

Burden of paraquat poisoning in the department of Antioquia, Colombia.

Buendía JA, Chavarriaga GJR, Zuluaga AF.

BMC Pharmacol Toxicol. 2019 Feb 15;20(1):11. doi: 10.1186/s40360-019-0291-0.

5.

Myoclonus induced by salbutamol: A case report

Montoya-Giraldo MA, Montoya DV, Atehortúa DA, Buendía JA, Zuluaga AF.

Biomedica. 2018 Sep 1;38(3):303-307. doi: 10.7705/biomedica.v38i3.3813.

6.

Survival Time to Biopsy-Proven Acute Rejection and Tacrolimus Adverse Drug Reactions in Pediatric Liver Transplantation.

Riva N, Dip M, Halac E, Cáceres Guido P, Woillard JB, Licciardone N, Chan D, Buendía J, Borgnia D, Bosaleh A, de Davila MT, Imventarza O, Schaiquevich P.

Ther Drug Monit. 2018 Aug;40(4):401-410. doi: 10.1097/FTD.0000000000000517.

PMID:
29621122
7.

[Cost-effectiveness of diagnostic strategies of severe bacterial infection in infants with fever without a source].

Buendía JA, Sánchez-Villamil JP, Urman G.

Biomedica. 2016 Sep 1;36(3):406-414. doi: 10.7705/biomedica.v36i3.2718. Spanish.

8.

Combinational Effect of CYP3A5 and MDR-1 Polymorphisms on Tacrolimus Pharmacokinetics in Liver Transplant Patients.

Buendía JA, Otamendi E, Kravetz MC, Cairo F, Ruf A, de Davila M, Powazniak Y, Nafissi J, Lazarowski A, Bramuglia G, Villamil F.

Exp Clin Transplant. 2015 Oct;13(5):441-8.

9.

IMPLICATIONS OF GLOBAL PRICING POLICIES ON ACCESS TO INNOVATIVE DRUGS: THE CASE OF TRASTUZUMAB IN SEVEN LATIN AMERICAN COUNTRIES.

Pichon-Riviere A, Garay OU, Augustovski F, Vallejos C, Huayanay L, Bueno Mdel P, Rodriguez A, de Andrade CJ, Buendía JA, Drummond M.

Int J Technol Assess Health Care. 2015 Jan;31(1-2):2-11. doi: 10.1017/S0266462315000094. Epub 2015 May 20.

PMID:
25989703
10.

[Flexible Fiberoptic Bronchoscopy in children with persistent atelectasis: a case series report].

Talamoni HL, Pisapia ND, Buendía JA.

Arch Argent Pediatr. 2015 Apr;113(2):e106-8. doi: 10.5546/aap.2015.e106. Spanish.

11.

[Physicians´ insight about adverse drug reaction to frequently used medication groups in Bogotá (Colombia)].

Buendía JA, Zuluaga AF.

Biomedica. 2014 Jul-Sep;34(3):403-8. doi: 10.1590/S0120-41572014000300010. Spanish.

PMID:
25504127
12.

An economic evaluation of trastuzumab as adjuvant treatment of early HER2-positive breast cancer patients in Colombia.

Buendía JA, Vallejos C, Pichón-Rivière A.

Biomedica. 2013 Jul-Sep;33(3):411-7.

PMID:
24652177
13.
14.

Costo-Efectividad de la Proteína C Reactiva, Procalcitonina y Escala de Rochester: Tres Estrategias Diagnosticas para la Identificación de Infección Bacteriana Severa en Lactantes Febriles sin Foco.

Antonio Buendía J, Colantonio L.

Value Health Reg Issues. 2013 Dec;2(3):375-380. doi: 10.1016/j.vhri.2013.10.001. Epub 2013 Dec 12.

PMID:
29702773
15.

Uso del Registro de Solicitudes de Medicamentos no Incluidos en el Listado de Medicamentos Esenciales como Nueva Fuente de Información en los Sistemas Nacionales de Farmacovigilancia.

Buendía JA, Zuluaga Salazar AF, Vacca González CP.

Value Health Reg Issues. 2013 Dec;2(3):357-360. doi: 10.1016/j.vhri.2013.10.005. Epub 2013 Dec 12.

PMID:
29702770
16.

[Attitudes, knowledge and beliefs of patient about anti-hypertensive drugs].

Buendía JA.

Biomedica. 2012 Oct-Dec;32(4):578-84. doi: 10.1590/S0120-41572012000400013. Spanish.

PMID:
23715233
17.

Burden and typing of rotavirus group A in Latin America and the Caribbean: systematic review and meta-analysis.

Linhares AC, Stupka JA, Ciapponi A, Bardach AE, Glujovsky D, Aruj PK, Mazzoni A, Rodriguez JA, Rearte A, Lanzieri TM, Ortega-Barria E, Colindres R.

Rev Med Virol. 2011 Mar;21(2):89-109. doi: 10.1002/rmv.682. Epub 2011 Mar 7. Review.

PMID:
21384462
18.

Chemoprophylaxis in contacts of patients with leprosy: systematic review and meta-analysis.

Reveiz L, Buendía JA, Téllez D.

Rev Panam Salud Publica. 2009 Oct;26(4):341-9. Review.

PMID:
20107683
19.

[Drug prescription patterns in patients attended at a middle- and high-complexity level institution].

Buendía-Rodriguez JA, Lopez-Gutierrez JJ, Garcia-Vega OA, Diaz-Rojas J, Sánchez-Villamil JP.

Rev Salud Publica (Bogota). 2008 Aug-Oct;10(4):605-14. Spanish.

20.

[The validity of a presumptive diagnosis of cutaneous leishmaniasis performed by community health workers in Colombia].

Sánchez J, Orozco L, Buendía J, Muñoz G.

Rev Panam Salud Publica. 2007 Jun;21(6):335-44. Spanish.

PMID:
17761045

Supplemental Content

Loading ...
Support Center